A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With Celecoxib Capsules, in Healthy Adult Subject

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

August 19, 2022

Study Completion Date

October 20, 2022

Conditions

Pharmacokinetics

Interventions

DRUG

PrimeC 748 mg

PrimeC is an extended release formulation of a fixed dose combination of ciprofloxacin and celecoxib

DRUG

Ciprofloxacin 750 MG

Ciprofloxacin

DRUG

Celecoxib 200mg

Celecoxib

Trial Locations (1)

Novum, Las Vegas